These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 9705415

  • 1. Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.
    Vazquez JA, Arganoza MT, Boikov D, Yoon S, Sobel JD, Akins RA.
    J Clin Microbiol; 1998 Sep; 36(9):2690-5. PubMed ID: 9705415
    [Abstract] [Full Text] [Related]

  • 2. In vitro interaction between amphotericin B and azoles in Candida albicans.
    Vazquez JA, Arganoza MT, Vaishampayan JK, Akins RA.
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2511-6. PubMed ID: 8913455
    [Abstract] [Full Text] [Related]

  • 3. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM, Reviákina V, Dolande M, Selgrad S.
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [Abstract] [Full Text] [Related]

  • 4. Patterns of amphotericin B killing kinetics against seven Candida species.
    Cantón E, Pemán J, Gobernado M, Viudes A, Espinel-Ingroff A.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2477-82. PubMed ID: 15215097
    [Abstract] [Full Text] [Related]

  • 5. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 6. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M, Deshpande LM, Davis AP, Rhomberg PR, Pfaller MA.
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [Abstract] [Full Text] [Related]

  • 7. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E, Bilgen H, Cerikçioğlu N, Ilki A, Ulger N, Bakır M, Akman I, Ozek E.
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [Abstract] [Full Text] [Related]

  • 8. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS, Chang SC, Hsueh PR, Wang JL, Sun HY, Chen YC.
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [Abstract] [Full Text] [Related]

  • 9. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D.
    Med Mycol; 1998 Aug; 36 Suppl 1():119-28. PubMed ID: 9988500
    [Abstract] [Full Text] [Related]

  • 10. Detection of Candida species resistant to azoles in the microbiota of rheas (Rhea americana): possible implications for human and animal health.
    Brilhante RSN, de Alencar LP, Cordeiro RA, Castelo-Branco DSCM, Teixeira CEC, Macedo RB, Lima DT, Paiva MAN, Monteiro AJ, Alves ND, Franco de Oliveira M, Sidrim JJC, Rocha MFG, Bandeira TJPG, Rodrigues TJS.
    J Med Microbiol; 2013 Jun; 62(Pt 6):889-895. PubMed ID: 23493027
    [Abstract] [Full Text] [Related]

  • 11. Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro.
    Scheven M, Schwegler F.
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1779-83. PubMed ID: 7486918
    [Abstract] [Full Text] [Related]

  • 12. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N, Alem N.
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [Abstract] [Full Text] [Related]

  • 13. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
    Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K, Antifungal Susceptibility Testing-AFST Study Group.
    Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
    [Abstract] [Full Text] [Related]

  • 14. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
    Wong-Beringera A, Hindler J, Brankovic L, Muehlbauer L, Steele-Moore L.
    Diagn Microbiol Infect Dis; 2001 Jan; 39(1):25-31. PubMed ID: 11173188
    [Abstract] [Full Text] [Related]

  • 15. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
    Kovacicova G, Krupova Y, Lovaszova M, Roidova A, Trupl J, Liskova A, Hanzen J, Milosovic P, Lamosova M, Macekova L, Szovenyiova Z, Purgelova A, Obertik T, Bille J, Krcmery V.
    J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
    [Abstract] [Full Text] [Related]

  • 16. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
    Cordeiro RA, Teixeira CE, Brilhante RS, Castelo-Branco DS, Paiva MA, Giffoni Leite JJ, Lima DT, Monteiro AJ, Sidrim JJ, Rocha MF.
    Med Mycol; 2013 Jan; 51(1):53-9. PubMed ID: 22712455
    [Abstract] [Full Text] [Related]

  • 17. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J, Rimek D, Kappe R.
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [Abstract] [Full Text] [Related]

  • 18. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
    Smith WL, Edlind TD.
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
    [Abstract] [Full Text] [Related]

  • 19. Post-antibiotic effect and post-expositional polyene antagonism of azole antifungal agents in Candida albicans: dependence on substance lipophilia.
    Scheven M, Scheven C, Hahn K, Senf A.
    Mycoses; 1995 Nov; 38(11-12):435-42. PubMed ID: 8720192
    [Abstract] [Full Text] [Related]

  • 20. Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against Candida species in an in vitro pharmacokinetic/pharmacodynamic model.
    Beredaki M-I, Arendrup MC, Pournaras S, Meletiadis J.
    Antimicrob Agents Chemother; 2024 Aug 07; 68(8):e0022524. PubMed ID: 38958455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.